Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Other Non Operating Income (2016 - 2026)

Champions Oncology has reported Other Non Operating Income over the past 17 years, most recently at $39000.0 for Q1 2026.

  • Quarterly results put Other Non Operating Income at $39000.0 for Q1 2026, up 105.26% from a year ago — trailing twelve months through Jan 2026 was $227000.0 (up 102.68% YoY), and the annual figure for FY2025 was $73000.0, up 52.08%.
  • Other Non Operating Income for Q1 2026 was $39000.0 at Champions Oncology, down from $70000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for CSBR hit a ceiling of $81000.0 in Q2 2024 and a floor of -$105000.0 in Q4 2023.
  • Median Other Non Operating Income over the past 5 years was $14000.0 (2023), compared with a mean of $13411.8.
  • Biggest five-year swings in Other Non Operating Income: plummeted 1066.67% in 2023 and later skyrocketed 1400.0% in 2025.
  • Champions Oncology's Other Non Operating Income stood at -$9000.0 in 2022, then plummeted by 1066.67% to -$105000.0 in 2023, then soared by 106.67% to $7000.0 in 2024, then skyrocketed by 900.0% to $70000.0 in 2025, then plummeted by 44.29% to $39000.0 in 2026.
  • The last three reported values for Other Non Operating Income were $39000.0 (Q1 2026), $70000.0 (Q4 2025), and $75000.0 (Q3 2025) per Business Quant data.